Stay updated on Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T12:50:14.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The NIH banner about its terminology transition is no longer displayed above the 403 Forbidden study-record page.
    Difference
    1%
    Check dated 2026-11-07T12:22:41.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T12:54:06.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A general NIH banner announces a transition in NIH website content and says that “Super Intelligence” may appear in place of “Artificial Intelligence.” It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-24T16:20:40.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:17:06.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The site footer revision advances from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T16:15:43.000Z thumbnail image

Stay in the know with updates to Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.